Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies

Current diagnostic and prognostic tools for prostate cancer (PC) are suboptimal, leading to overdiagnosis and overtreatment. Aberrant promoter hypermethylation of specific genes has been suggested as novel candidate biomarkers for PC that may improve diagnosis and prognosis. We here analyzed ST6GALN...

Descripción completa

Detalles Bibliográficos
Autores principales: Haldrup, Christa, Pedersen, Anne L., Øgaard, Nadia, Strand, Siri H., Høyer, Søren, Borre, Michael, Ørntoft, Torben F., Sørensen, Karina D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891052/
https://www.ncbi.nlm.nih.gov/pubmed/29465788
http://dx.doi.org/10.1002/1878-0261.12183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891052/
https://www.ncbi.nlm.nih.gov/pubmed/29465788
http://dx.doi.org/10.1002/1878-0261.12183

Ejemplares similares